Literature DB >> 8262627

Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans.

S M Levitz1, M P Dupont, E H Smail.   

Abstract

Lymphocytes constitute a critical component of host defenses against cryptococcosis. Previously, we demonstrated that human lymphocytes cultured with interleukin-2 formed conjugates with, and directly inhibited the growth of, Cryptococcus neoformans. Here, we explore the anticryptococcal activity of freshly isolated, highly purified populations of human peripheral blood lymphocytes. Lymphocytes were incubated with encapsulated C. neoformans for 24 h, after which the lymphocytes were lysed, dilutions and spread plates were made, and CFU were counted. Fungistasis was determined by comparing growth in wells with and without lymphocytes. Nylon wool-nonadherent peripheral blood mononuclear cells (NWNA PBMC) were highly fungistatic, even if either T cells or natural killer (NK) cells were depleted by panning. A mixed population of T cells and NK cells, obtained by rosetting NWNA PBMC with sheep erythrocytes, completely inhibited cryptococcal growth, whereas the nonrosetting cells had little fungistatic activity. CD4+, CD8+, and CD16/56+ lymphocytes, isolated by positive immunoselection, had potent growth-inhibitory activity. In contrast, purified B cells had no activity. Fungistasis was seen even in the absence of opsonins. Antifungal activity was markedly diminished when surface receptors on NWNA PBMC were cleaved by treatment with trypsin or bromelain. Supernatants from stimulated lymphocytes or concentrated lymphocyte sonicates were not active. Lymphocyte-mediated fungistasis was seen with two different strains of C. neoformans. CD4+, CD8+, and CD16/56+ lymphocytes formed conjugates with C. neoformans, as observed under Nomarski differential interference contrast microscopy and videomicroscopy. These data demonstrate that freshly isolated peripheral blood T cells and NK cells have the capacity to bind and directly inhibit the growth of C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8262627      PMCID: PMC186086          DOI: 10.1128/iai.62.1.194-202.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.

Authors:  R H Goldfarb; K Wasserman; R B Herberman; R P Kitson
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

Review 2.  T-cell-mediated cytotoxicity.

Authors:  G Berke
Journal:  Curr Opin Immunol       Date:  1991-06       Impact factor: 7.486

3.  Murine natural killer cells are fungicidal to Cryptococcus neoformans.

Authors:  M R Hidore; N Nabavi; F Sonleitner; J W Murphy
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

Review 4.  The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.

Authors:  S M Levitz
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

5.  Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans.

Authors:  S M Levitz
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation.

Authors:  L P Hale; B F Haynes
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

7.  Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.

Authors:  G Vachino; J A Gelfand; M B Atkins; J D Tamerius; P Demchak; J W Mier
Journal:  Blood       Date:  1991-11-15       Impact factor: 22.113

8.  Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells.

Authors:  G B Huffnagle; J L Yates; M F Lipscomb
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

9.  Signal transduction by the CD2 antigen in T cells and natural killer cells: requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16).

Authors:  L L Spruyt; M J Glennie; A D Beyers; A F Williams
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

10.  CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract.

Authors:  J O Hill
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

View more
  48 in total

1.  Cryptococcus gattii genotype VGI infection in New England.

Authors:  Russell J McCulloh; Raina Phillips; John R Perfect; Edmond J Byrnes; Joseph Heitman; Elizabeth Dufort
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

Review 2.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic Candidiasis.

Authors:  Manisha Shukla; Soma Rohatgi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 4.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

Review 5.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

6.  Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.

Authors:  S M Levitz; E A North; M P Dupont; T S Harrison
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans.

Authors:  G Arancia; A Molinari; P Crateri; A Stringaro; C Ramoni; M L Dupuis; M J Gomez; A Torosantucci; A Cassone
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide.

Authors:  S M Levitz; A Tabuni; S H Nong; D T Golenbock
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 9.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

10.  Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans.

Authors:  S M Levitz; A Tabuni; H Kornfeld; C C Reardon; D T Golenbock
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.